相关实验视频

Updated: Jan 13, 2026

Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression

Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression

Published on: February 24, 2023

精神分裂症与神经炎症的白天的潜在目标和生物活性成分:初步探索性综合性研究

Lina Guo¹, Bilin Zhang¹, Meiying Liu¹

¹School of Pharmaceutical Science, Shanxi Medical University, Taiyuan, 030001, People's Republic of China.

Journal of inflammation research

|October 29, 2025

概括

日间 (DYD) 显示出治疗精神分裂症相关的神经炎症 (SZNI) 的前景. 它的活性成分莱因向c-JUN通路,为SZNI提供了潜在的新治疗策略.

科学领域:

神经科学是一个神经科学.
药理学药理学是指药理学的学科.
传统中国医药传统中国医药

背景情况:

精神分裂症 (SZ) 与神经炎症 (SZNI) 有关.
目前的治疗方法 (SGA) 有代谢副作用,需要新的治疗方法.
传统中医药中的一种白日 (DYD) 显示出对SZNI的临床疗效,但其机制尚不清楚.

研究的目的:

阐明DYD在治疗SZNI中的分子机制.
确定SZNI.DYD的潜在治疗点和活性成分.
在分子水平上研究DYD和SZNI之间的相互作用.

主要方法:

生物信息学分析以确定SZNI中的关键调节器和基因模式.
分子对接和动力学模拟以评估药物向相互作用.
在体外实验 (CETSA,细胞培养) 以验证分子标和对神经炎症的影响.

主要成果:

生物信息学确定c-JUN是SZNI的关键调节者,而rhein是DYD的核心组成部分.
分子动力学和CETSA证实了c-JUN-Rhein复合物的稳定性.
实验室研究表明,莱因通过抑制JNK/c-JUN酸化来减少氧化应激和神经炎症.

结论:

这项研究为SZNI提供了第一个对DYD的全面分析.
c-JUN被确定为SZNI的潜在治疗标.
莱是DYD的关键活性成分,有可能开发用于SZNI的小分子疗法.

关键词:

传统中国医药传统中国医药生物信息学是一种生物信息学.机器学习是机器学习.分子对接的分子对接.分子动力学模拟模拟与精神分裂症相关的神经炎症.

更多相关视频

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

相关概念视频

Biological Causes of Schizophrenia

Biological Causes of Schizophrenia

Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...